Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Return on Assets (2016 - 2021)

Phio Pharmaceuticals' Return on Assets history spans 10 years, with the latest figure at 0.42% for Q3 2021.

  • For Q3 2021, Return on Assets rose 5.0% year-over-year to 0.42%; the TTM value through Sep 2021 reached 0.42%, up 5.0%, while the annual FY2020 figure was 0.74%, 2.0% up from the prior year.
  • Return on Assets reached 0.42% in Q3 2021 per PHIO's latest filing, down from 0.34% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.34% in Q2 2021 to a low of 2.57% in Q1 2018.
  • Average Return on Assets over 5 years is 1.03%, with a median of 0.77% recorded in 2018.
  • Peak YoY movement for Return on Assets: plummeted -155bps in 2018, then surged 207bps in 2019.
  • A 5-year view of Return on Assets shows it stood at 2.46% in 2017, then soared by 69bps to 0.77% in 2018, then fell by -29bps to 0.99% in 2019, then soared by 48bps to 0.52% in 2020, then rose by 19bps to 0.42% in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Return on Assets are 0.42% (Q3 2021), 0.34% (Q2 2021), and 0.41% (Q1 2021).